250
Views
23
CrossRef citations to date
0
Altmetric
Original Articles

SINGLE-CHAIN Fv ANTIBODY-ALKALINE PHOSPHATASE FUSION PROTEINS PRODUCED BY ONE-STEP CLONING AS RAPID DETECTION TOOLS FOR ELISA

, &
Pages 129-143 | Received 14 Jun 2001, Accepted 18 Jul 2001, Published online: 06 Feb 2007
 

ABSTRACT

A system was constructed for the production of alkaline phosphatase (aP)-labeled antibody single-chain Fv (scFv) fragments in Escherichia coli. The expression vector pASK75 was modified by sequentially inserting the E. coli aP coding region and the scFv cloning cassette. Engineering the cloning sites SfiI and NotI located at the 5′ and 3′ end of the scFv gene provides an easy means to insert scFv fragments. These cloning sites are widely used in recombinant antibody technology and, thus, enable the one-step cloning of scFv fragments derived from corresponding antibody phage libraries into the expression vector. An expressed herbicide-specific scFv–aP fusion protein retained both, analyte binding and enzymatic activity, as determined by ELISA. Therefore, this system permits the production of scFv–aP conjugates in E. coli, which can replace conventionally prepared aP-labeled antibodies in immunoassays. These fusion proteins are designed to accelerate the immunochemical detection of analytes, since the assay duration is essentially reduced by omitting the use of enzyme labeled secondary antibodies.

ACKNOWLEDGMENTS

We thank Prof. Arne Skerra (Technical University München, Center of Life and Food Sciences Weihenstephan, Germany) for providing the expression vector pASK75, and also Dr. Claudia Schmidt-Dannert (University Stuttgart, Institut für Technische Biochemie, Germany) for providing the E. coli alkaline phosphatase gene. This work was supported by the Deutsche Forschungsgemeinschaft (HO 383/35-1/2).

This paper is dedicated to Professor George Guilbault on the occasion of his 65th birthday.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.